Nighttime fasting may decrease breast cancer risk in women
the ONA take:
According to a recent study published in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers from the University of California, San Diego School of Medicine have found that a reduction in the amount of time spent eating and an increase in overnight fasting decreases glucose levels and may lower the risk of breast cancer among women.
In the study, participants reported eating five times per day with an average fasting of 12 hours during the nighttime. Women who reported longer fasting periods also consumed fewer calories during the day, ate fewer calories after 10 p.m, and had a fewer eating episodes.
Results showed that women who had a longer fasting duration overnight had significantly better glycemic control. In addition, researchers found that each 3 hour increase in overnight fasting was associated with a 4% lower postprandial glucose level.
The researchers note that larger studies are needed to confirm that overnight fasting improves glycemic control and reduces breast cancer risk.
An increase in overnight fasting decreases glucose levels and may lower the risk of breast cancer among women.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|